Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
批准号:
7662025
负责人:
Joey V. Barnett
金额:
$2.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2012-01-31
关键词:
AccountingAddressAdultAnimalsAppearanceBasic ScienceBlood VesselsCardiovascular DiseasesCell Differentiation processCell LineageCellsCessation of lifeClinicalCoronaryCoronary ArteriosclerosisCoronary VesselsDataDerivation procedureDevelopmentDiseaseDrug Delivery SystemsEmbryoEndothelial CellsEpicardiumEpithelialFailureGrowth Factor ReceptorsHumanIn VitroLaboratoriesMyocardiumNatureNull LymphocytesPathway interactionsRegulationRoleSignal PathwaySignal TransductionSmooth MuscleTGF beta type III receptorTestingTherapeuticTransforming Growth FactorsUnited StatesVenouscell behaviorimmortalized cellin vivoinjuredinsightnovelprogramsreceptorrepairedresearch studyvascular bedvasculogenesis
中文摘要
描述(由申请人提供):冠状动脉疾病占美国所有心血管疾病的54%。了解冠状血管如何发育可能会发现新的药物靶点和治疗策略,有助于指导成人冠状血管的修复或重塑。我们实验室最近的数据表明,III型转化生长因子2受体(TGF2R3)的靶向缺失导致与冠状血管形成或持续失败相关的胚胎死亡,而其他血管床似乎正常发育。实验旨在确定TGF2R3的缺失是如何导致冠状血管发育失败的,并揭示调节心外膜细胞分化的TGF2信号通路。我们将测试3个特定的假设。假设1:TGF2R3是适当的心外膜分化所必需的。这将通过野生型、杂合子Tgfbr3缺失和纯合子Tgfbr3缺失动物的心外膜和心外膜衍生物的体内分析来验证。假设2:TGF2R3在心外膜或心肌中是冠状血管正常发育所必需的。这将通过心外膜和心肌Tgfbr3的条件缺失来验证。假设3:特定的TGF2信号通路调节心外膜细胞分化。这将在野生型、杂合子Tgfbr3缺失和纯合子Tgfbr3缺失动物的外植体和永生化细胞中进行体外测试。该实验的成功完成将对转化生长因子2 (TGF2)在冠状血管发育中的作用产生重要的见解。冠状动脉起源的独特性和冠状动脉疾病在人类中的重要性使得确定TGF2R3调控冠状动脉血管形成的机制无论从基础科学还是临床角度都具有重要意义。
英文摘要
DESCRIPTION (provided by applicant): Coronary artery disease accounts for 54% of all cardiovascular disease in the United States [1]. Understanding how coronary vessels develop is likely to uncover novel drug targets and therapeutic strategies useful in directing the repair or remodeling of coronary vessels in adults. Recent data from our laboratory has demonstrated that targeted deletion of the Type III Transforming Growth Factor 2 receptor (TGF2R3) results in embryonic death associated with failure of the formation or persistence of the coronary vessels while other vascular beds appear to develop normally. Experiments are proposed to identify how the loss of TGF2R3 results in the failure of coronary vessel development and to reveal the TGF2 signaling pathways that regulate epicardial cell differentiation. We will test 3 specific hypotheses. Hypothesis 1: TGF2R3 is required for proper epicardial differentiation. This will be tested by in vivo analysis of the epicardium and epicardial derivatives in wildtype, heterozygous Tgfbr3 null, and homozygous Tgfbr3 null animals. Hypothesis 2: TGF2R3 is required in the epicardium or myocardium for proper coronary vessel development. This will be tested by conditional deletion of Tgfbr3 in the epicardium and myocardium. Hypothesis 3: Specific TGF2 signaling pathways regulate epicardial cell differentiation. This will be tested in vitro in both explants and immortalized cells from wildtype, heterozygous Tgfbr3 null, and homozygous Tgfbr3 null animals The successful completion of the proposed experiments will yield significant insight into the role of Transforming Growth Factor 2 (TGF2) in coronary vessel development. The unique nature of the derivation of the coronary vessels and the significance of coronary vessel disease in humans makes the determination of the mechanisms behind TGF2R3 regulation of coronary vasculogenesis of high significance from both a basic science and clinical perspective.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vanderbilt Experimental Research Training Inclusion Community Engagement Skills (VERTICES)
-
批准号:10470962
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2020
-
负责人:Joey V. Barnett
-
依托单位:
Vanderbilt Experimental Research Training Inclusion Community Engagement Skills (VERTICES)
-
批准号:10267758
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2020
-
负责人:Joey V. Barnett
-
依托单位:
Vanderbilt Experimental Research Training Inclusion Community Engagement Skills (VERTICES)
-
批准号:10685263
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2020
-
负责人:Joey V. Barnett
-
依托单位:
Promoting Academic Excellence through Community Engagement and Research Scholars Program (PAECER Scholars Program)
-
批准号:10545048
-
项目类别:
-
资助金额:$11.86万
-
财政年份:2019
-
负责人:Joey V. Barnett
-
依托单位:
Promoting Academic Excellence through Community Engagement and Research Scholars Program (PAECER Scholars Program)
-
批准号:10337027
-
项目类别:
-
资助金额:$11.84万
-
财政年份:2019
-
负责人:Joey V. Barnett
-
依托单位:
Promoting Academic Excellence through Community Engagement and Research Scholars Program (PAECER Scholars Program)
-
批准号:10092825
-
项目类别:
-
资助金额:$8.73万
-
财政年份:2019
-
负责人:Joey V. Barnett
-
依托单位:
National Pharmacology Directors of Graduate Programs Meeting
-
批准号:8597091
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2014
-
负责人:Joey V. Barnett
-
依托单位:
National Pharmacology Directors of Graduate Programs Meeting
-
批准号:7675163
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2009
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:7919822
-
项目类别:
-
资助金额:$1.64万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:7379859
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:8098399
-
项目类别:
-
资助金额:$2.79万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:7556763
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:7763812
-
项目类别:
-
资助金额:$42.57万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development
-
批准号:7662024
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2008
-
负责人:Joey V. Barnett
-
依托单位:
National Pharmacology Directors of Graduate Programs Meeting
-
批准号:7277949
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2007
-
负责人:Joey V. Barnett
-
依托单位:
Training Program in Cardiovascular Pharmacology
-
批准号:7388269
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2004
-
负责人:Joey V. Barnett
-
依托单位:
Training Program in Cardiovascular Pharmacology
-
批准号:7214832
-
项目类别:
-
资助金额:$25.32万
-
财政年份:2004
-
负责人:Joey V. Barnett
-
依托单位:
TGF beta and coronary vessel development
-
批准号:6893309
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2004
-
负责人:Joey V. Barnett
-
依托单位:
Core--Morphology and imaging
-
批准号:6893312
-
项目类别:
-
资助金额:$21.48万
-
财政年份:2004
-
负责人:Joey V. Barnett
-
依托单位:
Training Program in Cardiovascular Pharmacology
-
批准号:7007679
-
项目类别:
-
资助金额:$25.16万
-
财政年份:2004
-
负责人:Joey V. Barnett
-
依托单位:
海外基金